Article
TFEB triggers a matrix degradation and invasion program in triple-negative breast cancer cells upon mTORC1 repression
26 Dec 2024
Abstract excerpt
The phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway is frequently hyperactivated in triple-negative breast cancers (TNBCs) associated with poor prognosis and is a therapeutic target in breast cancer management. Here, we describe the effects of repression of mTOR-containing complex 1 (mTORC1) through knockdown of several key mTORC1 components or with mTOR inhibitors used in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
